secwatch.observer — SEC 8-K summary
======================================

Issuer:     MERIDIAN BIOSCIENCE INC (—)
CIK:        0000794172
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0001193125-23-021179
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SD Biosensor/SJL Partners complete $34/share acquisition of Meridian Bioscience; stock to be delisted
--------------------------------------------------------------------------------

- Merger closed on Jan 31, 2023; shareholders receive $34.00 per share in cash.
- Meridian's common stock to be delisted from NASDAQ; Form 25 to be filed.
- New board: Jack Kenny and Andrew Kitzmiller elected; prior directors resigned.
- Meridian entered $500M term loan and $50M revolving credit facility, maturing Jan 2028.
- Prior credit agreement terminated; all outstanding loans repaid in full.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/794172/000119312523021179/0001193125-23-021179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/794172/000119312523021179/d448822d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-021179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer